Polymer-Coated Virus Particles for Oral Vaccine Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current oral virus vaccines are unstable in low pH environments of the gastrointestinal tract, leading to reduced effectiveness in delivering the vaccine to the intestines, where they are needed to prevent viral infections such as porcine epidemic diarrhea (PED) in pigs.

Innovation Solution

A polymer-coated virus particle formulation comprising a cationic polymer layer and a pH-sensitive polymer layer surrounding the virus particles, which can maintain stability and integrity at low pH conditions, allowing effective delivery to the intestines without destruction.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If oral virus vaccines are administered directly, then easy administration is achieved, but the vaccine becomes unstable in the low pH environment of the gastrointestinal tract

Engineering Contradiction:
Improveease of administrationVSAvoidstability in low pH environment
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The vaccine is formulated as a composite material consisting of virus particles embedded in a polymer matrix. This composite structure provides both the biological activity of the virus and the protective properties of the polymer, resolving the contradiction between ease of administration and stability in low pH environment.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The polymer matrix changes its physical properties (such as swelling or degradation) in response to pH changes. At low pH in the stomach, the polymer remains intact to protect the virus, while at higher pH in the intestines, the polymer undergoes transformation to release the virus particles, thus adapting to different environmental conditions.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If the vaccine is protected from gastric acid, then delivery stability is improved, but the vaccine structure becomes more complex

Engineering Contradiction:
Improvedelivery stabilityVSAvoidvaccine structure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

A polymer matrix acts as a flexible protective shell surrounding the virus particles. This shell is simple in structure but effective in function, providing protection against gastric acid while allowing controlled release in the intestines, thus improving delivery stability without significantly increasing complexity.

Inventive Principle:
Principle #30Flexible shells and thin films

Solution Approach 2:

The polymer matrix serves as an intermediary between the harsh gastric environment and the sensitive virus particles. It mediates the interaction by absorbing the shock of low pH and gradually releasing the virus in a controlled manner, simplifying the overall protection mechanism while maintaining high delivery stability.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The polymer-coated virus particles remain stable and intact in the low pH environment of the gastrointestinal tract, enhancing the efficacy of vaccine delivery and prevention of viral infections by maintaining the integrity of the vaccine particles and facilitating their release at intestinal pH conditions.

Implementation Method 1

a cationic polymer layer; and a pH-sensitive polymer layer, wherein the cationic polymer layer and the pH-sensitive polymer layer are formed to surround one or more virus particles

Methodology Applied
Scientific EffectElectrostatic interaction: Electrostatics

Implementation Method 2

a pH-sensitive polymer layer, wherein the cationic polymer layer and the pH-sensitive polymer layer are formed to surround one or more virus particles

Methodology Applied
Scientific EffectpH-sensitive response:

Data Source

PatentUS10136662B2Oral virus vaccine
Publication Date: 2018.11.27 IND ACADEMIC COOP FOUND YONSEI UNIV
  • US10136662B2 patent drawing
  • US10136662B2 patent drawing

AI summary

The present disclosure relates to a polymer-coated virus particle for an oral virus vaccine, a method of preparing the same, and a composition comprising the same. In accordance with the present disclosure, the oral virus vaccine can be effectively delivered to the intestines without being destroyed even in the low pH environment of the gastrointestinal tract, then the prevention efficacy against viral infections can be improved.